Literature DB >> 12145594

Predicting which patients can undergo upper endoscopy comfortably without conscious sedation.

Neena Abraham1, Alan Barkun, Martin Larocque, Carlo Fallone, Serge Mayrand, Vicky Baffis, Albert Cohen, Donald Daly, Habib Daoud, Lawrence Joseph.   

Abstract

BACKGROUND: Eliminating conscious sedation for diagnostic endoscopy may be advantageous for patient safety and cost containment. The aim of this study was to identify and validate independent predictors of a comfortable, technically adequate, unsedated diagnostic upper endoscopy in Canadian patients.
METHODS: Patients were consecutively enrolled in a prospective fashion. Data collected on an initial cohort of 268 patients included demographics, a validated anxiety questionnaire, use of sedatives/analgesics, upper endoscopy experience, pharyngeal sensitivity, technical adequacy, and patient assessment of comfort after the procedure. The main outcome measure was "satisfactory upper endoscopy," a composite of optimal scores for patient comfort and technical adequacy. Univariate and multivariate analyses were performed to identify the optimal predictive model of a satisfactory unsedated diagnostic upper endoscopy. Once identified, 68 additional patients were enrolled in a similar fashion from an independent prospective sample for purposes of outcome validation. Multivariate analysis was then repeated with the total cohort (N = 336). These results were then compared for concordance with those obtained from the initial cohort.
RESULTS: Among the initial 268 patients (54.3% women; mean age 51 +/- 17 years), 49% were anxious, 15% regularly used sedatives and analgesics, 28% experienced increased pharyngeal sensitivity, and 41% had previously undergone upper endoscopy. Endoscopy was completed in 94.7% of patients without sedation and was technically adequate in 97%, and 80.1% were willing to repeat the procedure under similar conditions. Satisfactory upper endoscopy was achieved in only 59% of the initial cohort. The only independent and significant predictors of a satisfactory upper endoscopy were advancing age (OR 1.2: 95% CI [1.1, 1.4]) and decreased pharyngeal sensitivity (OR 0.5: 95% CI [0.27, 0.93]). Concordance of results were noted after validation with the second cohort. Satisfactory endoscopy was achieved in only 59.5% of the total cohort (n = 336); only 61% reported a comfortable procedural experience.
CONCLUSIONS: The proportion of patients who can comfortably undergo technically adequate unsedated upper endoscopy is modest. Unsedated upper endoscopy is most likely to be successful under these procedural conditions in patients of advancing age with decreased pharyngeal sensitivity. The generalizability of these findings to an American population requires further study and may assist in identifying a subgroup of patients in whom it is cost-effective to perform upper endoscopy comfortably without sedation.

Entities:  

Mesh:

Year:  2002        PMID: 12145594     DOI: 10.1016/s0016-5107(02)70175-2

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  18 in total

1.  Feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human stomach: a pilot study in healthy volunteers.

Authors:  Zhuan Liao; Xiao-Dong Duan; Lei Xin; Lu-Min Bo; Xin-Hong Wang; Guo-Hua Xiao; Liang-Hao Hu; Song-Lin Zhuang; Zhao-Shen Li
Journal:  J Interv Gastroenterol       Date:  2012-10-01

2.  Office-based unsedated ultrathin esophagoscopy in a primary care setting.

Authors:  Thad Wilkins; Ralph A Gillies
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

3.  Unsedated transnasal upper gastrointestinal endoscopy has favorable diagnostic effectiveness, cardiopulmonary safety, and patient satisfaction compared with conventional or sedated endoscopy.

Authors:  Zheng-Lin Ai; Chun-Hui Lan; Li-Lin Fan; Li Lan; Yan Cao; Ping Li; Ou Song; Dong-Feng Chen
Journal:  Surg Endosc       Date:  2012-09-14       Impact factor: 4.584

4.  Sedation for gastroscopy: Is it an adequately understood and informed choice?

Authors:  L Quinn; M E Kelly; A Khan; R Irwin; W Khan; K Barry; R Waldron; I Z Khan
Journal:  Ir J Med Sci       Date:  2015-09-10       Impact factor: 1.568

5.  Transnasal endoscopic biliary drainage as a rescue management for the treatment of acute cholangitis.

Authors:  Takao Itoi; Atushi Sofuni; Fumihide Itokawa; Takayoshi Tsuchiya; Toshio Kurihara; Kentaro Ishii; Shujiro Tsuji; Nobuhito Ikeuchi; Fuminori Moriyasu
Journal:  World J Gastrointest Endosc       Date:  2010-02-16

6.  Single use of fentanyl in colonoscopy is safe and effective and significantly shortens recovery time.

Authors:  G Lazaraki; J Kountouras; S Metallidis; S Dokas; T Bakaloudis; D Chatzopoulos; E Gavalas; C Zavos
Journal:  Surg Endosc       Date:  2007-02-16       Impact factor: 4.584

7.  Upper gastrointestinal endoscopy: are preparatory interventions or conscious sedation effective? A randomized trial.

Authors:  Lucio Trevisani; Sergio Sartori; Piergiorgio Gaudenzi; Giuseppe Gilli; Giancarlo Matarese; Sergio Gullini; Vincenzo Abbasciano
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Factors Associated with Upper Gastrointestinal Cancer Occurrence After Endoscopy that Did Not Diagnose Cancer.

Authors:  Danny Cheung; Shyam Menon; Jonathan Hoare; Anjan Dhar; Nigel Trudgill
Journal:  Dig Dis Sci       Date:  2016-04-29       Impact factor: 3.199

9.  Propofol sedation versus no sedation in detection of pharyngeal and upper gastrointestinal superficial squamous cell carcinoma using endoscopic narrow band imaging: a multicenter prospective trial.

Authors:  Yuqi He; Yuqing Zhao; Kuangi Fu; Yongqiang Du; Jin Yu; Jianxun Wang; Peng Jin; Xiaojun Zhao; Na Li; Hua Guo; Jiandong Li; Fayun Zhao; Jianqiu Sheng
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Meperidine for patients expected to have poor tolerance to esophagogastroduodenoscopy: A double-blind, randomized, controlled study.

Authors:  Chih-Wei Tseng; Malcolm Koo; Kuo-Chih Tseng; Yu-Hsi Hsieh
Journal:  United European Gastroenterol J       Date:  2018-08-24       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.